Divergent Moves by Major Funds Frame Aixtron's Pivotal Year

Aixtron stock surges over 90% YTD despite a weak Q1 forecast. Major investors like Morgan Stanley and BlackRock take opposite positions ahead of earnings, highlighting a split on near-term vs. long-term potential.

As Aixtron prepares to release its first-quarter figures, the semiconductor equipment manufacturer presents a complex picture for investors. The stock has surged more than 90% since the start of the year, yet the company has pre-announced a significant quarterly shortfall. This contrast is mirrored in the recent, opposing actions of two of the world's largest institutional investors.

Institutional Investors Take Opposite Sides

Regulatory filings on April 1 revealed a split in sentiment among heavyweight shareholders. Morgan Stanley increased its stake in Aixtron to 4.81%. On the same day, BlackRock slightly reduced its holding, moving from 7.46% to 7.43%. While each move is minor in isolation, their occurrence just ahead of quarterly results highlights a divergence in how major funds are assessing the company's near-term trajectory versus its long-term potential.

This institutional divide is reflected in analyst commentary. Barclays maintains its 'Overweight' rating, citing structural demand for gallium nitride power electronics, which are increasingly required for powering AI data centers. Morgan Stanley raised its price target from €25 to €35, though it kept an 'Equal-weight' stance. Both JPMorgan and Jefferies reaffirmed their price targets of €36.50 per share.

A Weak Quarter Amid a Powerful Rally

The company's management has already guided for a soft Q1, with expected revenue of approximately €65 million—far below the average analyst forecast of €111 million. This weakness is primarily attributed to ongoing challenges in the silicon carbide (SiC) segment, where significant overcapacity in silicon carbide equipment is suppressing demand. For the full 2026 fiscal year, Aixtron anticipates revenue below the prior year's level, with an EBIT margin projected between 16% and 19%.

Despite this outlook, the equity has demonstrated remarkable strength. The substantial year-to-date gain is less about current operations and more rooted in the medium-term investment thesis. Management forecasts that demand for datacom lasers will more than double in 2026 compared to the previous year, driven by AI infrastructure build-out and the positioning of its G10-AsP platform in indium phosphide epitaxy.

Financial Strength and Strategic Expansion

Aixtron's balance sheet provides a solid foundation for its strategy. The company boasts an equity ratio of 88% and holds liquid assets of €224.6 million. This financial health supports a significant capacity expansion plan.

The firm is allocating roughly €40 million across 2026 and 2027 to establish a new facility in Malaysia. This site will handle assembly, testing, and engineering support for Asian customers, with initial deliveries scheduled for late 2027. The investment is a direct bet on securing capacity for an anticipated wave of demand in the global semiconductor market and underpins much of the persistent investor optimism.

Key Dates on the Horizon

Two imminent events will set the tone for the coming months. On April 30, 2026, Aixtron will publish its formal Q1 report. The order intake disclosed will be critical, indicating whether the Asian capacity expansion is backed by tangible demand or if operational performance is lagging even further behind expectations.

The Annual General Meeting follows on May 13, 2026. Despite an expected decline in profits, the management and supervisory boards propose an unchanged dividend of €0.15 per share. Shareholders will also vote on the creation of a new Authorized Capital 2026 and new convertible bond instruments. These mechanisms would grant the company greater financing flexibility for future initiatives.